{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:05:16Z","timestamp":1792440316757,"version":"4.5.0"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl. 5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2314,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Hepatitis B virus (HBV) infects more than 300 million people worldwide and is a common cause of liver disease and liver cancer. HBV, a member of the\n                      <jats:italic toggle=\"yes\">Hepadnaviridae<\/jats:italic>\n                      family, is a small DNA virus with unusual features similar to retroviruses. HBV replicates through an RNA intermediate and can integrate into the host genome. The unique features of the HBV replication cycle confer a distinct ability of the virus to persist in infected cells. Virological and serological assays have been developed for diagnosis of various forms of HBV-associated disease and for treatment of chronic hepatitis B infection. HBV infection leads to a wide spectrum of liver disease ranging from acute (including fulminant hepatic failure) to chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Acute HBV infection can be either asymptomatic or present with symptomatic acute hepatitis. Most adults infected with the virus recover, but 5%-10% are unable to clear the virus and become chronically infected. Many chronically infected persons have mild liver disease with little or no long-term morbidity or mortality. Other individuals with chronic HBV infection develop active disease, which can progress to cirrhosis and liver cancer. These patients require careful monitoring and warrant therapeutic intervention. Extrahepatic manifestations of HBV infection are rare but can be difficult to diagnose and manage. The challenges in the area of HBV-associated disease are the lack of knowledge in predicting outcome and progression of HBV infection and an unmet need to understand the molecular, cellular, immunological, and genetic basis of various disease manifestations associated with HBV infection. (Hepatology 2009;49:S13\u2013S21.)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.22881","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T08:28:53Z","timestamp":1278318533000},"page":"S13-S21","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":868,"title":["Hepatitis B: The virus and disease #"],"prefix":"10.1097","volume":"49","author":[{"given":"Jake T.","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-3-20241201","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1016\/S0021-9258(18)34448-X","article-title":"Structure of hepatitis B surface antigen: characterization of the lipid components and their association with the viral proteins.","volume":"257","author":"Gavilanes","year":"1982","journal-title":"J Biol Chem"},{"key":"R4-3-20241201","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0092-8674(80)90443-2","article-title":"Hepatitis B virus contains protein attached to the 5 end of its complete strand.","volume":"21","author":"Gerlich","year":"1980","journal-title":"Cell"},{"key":"R5-3-20241201","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1128\/jvi.66.9.5232-5241.1992","article-title":"RNA and DNAbinding activities in hepatitis B virus capsid protein: a model for their roles in viral replication.","volume":"66","author":"Hatton","year":"1992","journal-title":"J Virol"},{"key":"R6-3-20241201","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/jhep.2003.50453","article-title":"Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.","volume":"38","author":"Milich","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R7-3-20241201","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1172\/JCI200113787","article-title":"Xdeficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo.","volume":"108","author":"Zhang","year":"2001","journal-title":"J Clin Invest"},{"key":"R8-3-20241201","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1073\/pnas.90.17.8078","article-title":"Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogenactivated cellular serinethreonine kinases.","volume":"90","author":"Cross","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-3-20241201","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1128\/JVI.80.3.1405-1413.2006","article-title":"Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver.","volume":"80","author":"Hu","year":"2006","journal-title":"J Virol"},{"key":"R10-3-20241201","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1128\/JVI.78.23.12725-12734.2004","article-title":"The enigmatic X gene of hepatitis B virus.","volume":"78","author":"Bouchard","year":"2004","journal-title":"J Virol"},{"key":"R11-3-20241201","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.3961490","article-title":"Genetic and biochemical evidence for the hepatitis B virus replication strategy.","volume":"232","author":"Seeger","year":"1986","journal-title":"Science"},{"key":"R12-3-20241201","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1126\/science.2554495","article-title":"A liverspecific enhancer in the core promoter region of human hepatitis B virus.","volume":"246","author":"Yee","year":"1989","journal-title":"Science"},{"key":"R13-3-20241201","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.83.6.1627","article-title":"Hepatitis B virus DNA contains a glucocortcoid response element.","volume":"83","author":"TurKaspa","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-3-20241201","first-page":"7476","article-title":"A novel hepatitis B virus (HBV) genetic element with Rev response elementlike properties that is essential for expression of HBV gene products.","volume":"13","author":"Huang","year":"1993","journal-title":"Mol Cell Biol"},{"key":"R15-3-20241201","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1128\/jvi.67.12.7414-7422.1993","article-title":"Hepadnavirus infection requires interaction between the viral preS domain and a specific hepatocellular receptor.","volume":"67","author":"Klingmuller","year":"1993","journal-title":"J Virol"},{"key":"R16-3-20241201","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/JVI.72.10.8098-8104.1998","article-title":"Carboxypeptidase D (gp180), a Golgiresident protein, functions in the attachment and entry of avian hepatitis B viruses.","volume":"72","author":"Breiner","year":"1998","journal-title":"J Virol"},{"key":"R17-3-20241201","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1042\/BJ20060347","article-title":"Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly.","volume":"398","author":"Kang","year":"2006","journal-title":"Biochem J"},{"key":"R18-3-20241201","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1128\/jvi.67.8.4867-4874.1993","article-title":"Analysis of the earliest steps of hepadnavirus replication genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity.","volume":"67","author":"Kock","year":"1993","journal-title":"J Virol"},{"key":"R19-3-20241201","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1128\/jvi.63.12.5451-5454.1989","article-title":"Internal entry of ribosomes and ribosomal scanning involved in hepatitis B virus P gene expression.","volume":"63","author":"JeanJean","year":"1989","journal-title":"J Virol"},{"key":"R20-3-20241201","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/jvi.61.5.1672-1677.1987","article-title":"The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid.","volume":"61","author":"Persing","year":"1987","journal-title":"J Virol"},{"key":"R21-3-20241201","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/jvi.67.6.3254-3263.1993","article-title":"An RNA stemloop structure directs hepatitis B virus genomic RNA encapsidation.","volume":"67","author":"Pollack","year":"1993","journal-title":"J Virol"},{"key":"R22-3-20241201","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/jvi.61.3.904-911.1987","article-title":"Replication strategy of human hepatitis B virus.","volume":"61","author":"Will","year":"1987","journal-title":"J Virol"},{"key":"R23-3-20241201","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM197901183000301","article-title":"Viral hepatitis, type B. Studies on natural history and prevention reexamined.","volume":"300","author":"Krugman","year":"1979","journal-title":"N Engl J Med"},{"key":"R24-3-20241201","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJMe020060","article-title":"Hepatitis B e antigen-the dangerous endgame of hepatitis B.","volume":"347","author":"Liang","year":"2002","journal-title":"N Engl J Med"},{"key":"R25-3-20241201","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1537-2995.1981.21381201816.x","article-title":"Antibody to hepatitis B core antigen in blood donors with a history of hepatitis.","volume":"21","author":"Tabor","year":"1981","journal-title":"Transfusion"},{"key":"R26-3-20241201","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0016-5085(83)80244-3","article-title":"Antihepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and nonA, nonB viruses.","volume":"85","author":"Perrillo","year":"1983","journal-title":"Gastroenterology"},{"key":"R27-3-20241201","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2007.11.036","article-title":"Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.","volume":"134","author":"Pawlotsky","year":"2008","journal-title":"Gastroenterology"},{"key":"R28-3-20241201","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03256447","article-title":"New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.","volume":"10","author":"Kuhns","year":"2006","journal-title":"Mol Diagn Ther"},{"issue":"Suppl 3","key":"R29-3-20241201","doi-asserted-by":"crossref","first-page":"H33","DOI":"10.1177\/135965350701203S05","article-title":"Treatment of chronic hepatitis B.","volume":"12","author":"Loomba","year":"2007","journal-title":"Antivir Ther"},{"key":"R30-3-20241201","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.","volume":"151","author":"McMahon","year":"1985","journal-title":"J Infect Dis"},{"key":"R31-3-20241201","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000441-197201000-00005","article-title":"Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis-associated antigen.","volume":"263","author":"Barker","year":"1972","journal-title":"Am J Med Sci"},{"key":"R32-3-20241201","first-page":"349","article-title":"Fulminant hepatic failure.","volume":"69","author":"Berk","year":"1978","journal-title":"Am J Gastroenterol"},{"key":"R33-3-20241201","first-page":"240","article-title":"Fulminant hepatic failure: summary of a workshop.","volume":"21","author":"Hoofnagle","year":"1995","journal-title":"HEPATOLOGY"},{"issue":"suppl","key":"R34-3-20241201","first-page":"S45","article-title":"The natural history of chronic hepaatitis B virus infection.","volume":"49","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R35-3-20241201","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-101-5-613","article-title":"Survival in chronic hepatitis B. An analysis of 379 patients.","volume":"101","author":"Weissberg","year":"1984","journal-title":"Ann Intern Med"},{"key":"R36-3-20241201","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hep.1840080310","article-title":"The development of cirrhosis in patients with chronic type B hepatitis: a prospective study.","volume":"8","author":"Liaw","year":"1988","journal-title":"HEPATOLOGY"},{"key":"R37-3-20241201","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/0016-5085(92)91188-A","article-title":"Survival and prognostic indicators in hepatitis B surface antigenpositive cirrhosis of the liver.","volume":"103","author":"de Jongh","year":"1992","journal-title":"Gastroenterology"},{"key":"R38-3-20241201","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/hep.1840090119","article-title":"Alphafetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.","volume":"9","author":"Lok","year":"1989","journal-title":"HEPATOLOGY"},{"key":"R39-3-20241201","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-2006-951606","article-title":"Serum markers of hepatocellular carcinoma.","volume":"26","author":"Spangenberg","year":"2006","journal-title":"Semin Liver Dis"},{"key":"R40-3-20241201","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2008-1063929","article-title":"Hepatitis B as an immune complex disease.","volume":"1","author":"Dienstag","year":"1981","journal-title":"Semin Liver Dis"},{"key":"R41-3-20241201","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/jaut.2000.0502","article-title":"Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis.","volume":"16","author":"Trepo","year":"2001","journal-title":"J Autoimmun"},{"key":"R42-3-20241201","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM197107222850401","article-title":"The pathogenesis of arthritis associated with viral hepatitis. Complementcomponent studies.","volume":"285","author":"Alpert","year":"1971","journal-title":"N Engl J Med"},{"key":"R43-3-20241201","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(70)90339-9","article-title":"Association between polyarteritis and Australia antigen.","volume":"2","author":"Gocke","year":"1970","journal-title":"Lancet"},{"key":"R44-3-20241201","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults.","volume":"324","author":"Lai","year":"1991","journal-title":"N Engl J Med"},{"key":"R45-3-20241201","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(78)91801-9","article-title":"Strong association between membranous nephropathy and hepatitisB surface antigenaemia in Japanese children.","volume":"2","author":"Takekoshi","year":"1978","journal-title":"Lancet"},{"key":"R46-3-20241201","first-page":"S40","article-title":"Clinical features and the natural course of hepatitis B virusrelated glomerulopathy in adults.","volume":"35","author":"Lai","year":"1991","journal-title":"Kidney Int Suppl"},{"key":"R47-3-20241201","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(76)93087-7","article-title":"An epidemic of infantile papular acrodermatitis (Gianottis disease) in Japan associated with hepatitisB surface antigen subtype ayw.","volume":"1","author":"Ishimaru","year":"1976","journal-title":"Lancet"},{"key":"R48-3-20241201","first-page":"1044","article-title":"Hepatitis B virus infection in patients with idiopathic liver disease.","volume":"13","author":"Liang","year":"1991","journal-title":"HEPATOLOGY"},{"key":"R49-3-20241201","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.1840120205","article-title":"Characterization and biological properties of a hepatitis B isolated from a patient without HBV serologic markers.","volume":"12","author":"Liang","year":"1990","journal-title":"HEPATOLOGY"},{"key":"R50-3-20241201","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199007123230202","article-title":"Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen.","volume":"323","author":"Paterlini","year":"1990","journal-title":"N Engl J Med"},{"key":"R51-3-20241201","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","article-title":"The hepatitis B virus persists for decades after patients recovery from acute viral hepatitis despite active maintenance of a cytotoxic Tlymphocyte response.","volume":"2","author":"Rehermann","year":"1996","journal-title":"Nat Med"},{"key":"R52-3-20241201","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.510270526","article-title":"Persistent viremia after recovery from selflimited acute hepatitis B.","volume":"27","author":"Yotsuyanagi","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R53-3-20241201","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1128\/jvi.63.3.1360-1370.1989","article-title":"Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues.","volume":"63","author":"Korba","year":"1989","journal-title":"J Virol"},{"key":"R54-3-20241201","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(88)92891-7","article-title":"Transmission of hepatitis B from hepatitisBseronegative subjects.","volume":"2","author":"Thiers","year":"1988","journal-title":"Lancet"},{"key":"R55-3-20241201","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1053\/gast.1997.v113.pm9352871","article-title":"Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.","volume":"113","author":"Dickson","year":"1997","journal-title":"Gastroenterology"},{"key":"R56-3-20241201","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00007890-199810150-00012","article-title":"Reactivation of hepatitis B after transplantation in patients with preexisting antihepatitis B surface antigen antibodies: report on three cases and review of the literature.","volume":"66","author":"Blanpain","year":"1998","journal-title":"Transplantation"},{"key":"R57-3-20241201","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.","volume":"100","author":"Lok","year":"1991","journal-title":"Gastroenterology"},{"key":"R58-3-20241201","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAgnegative patients undergoing cytotoxic chemotherapy.","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"R59-3-20241201","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","article-title":"Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.","volume":"148","author":"Loomba","year":"2008","journal-title":"Ann Intern Med"},{"key":"R60-3-20241201","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/jvi.65.4.1836-1842.1991","article-title":"Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication.","volume":"65","author":"Blum","year":"1991","journal-title":"J Virol"},{"key":"R61-3-20241201","first-page":"273","article-title":"A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers.","volume":"21","author":"Hou","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R62-3-20241201","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.510230301","article-title":"A molecular analysis of viral persistence in surface antigennegative chronic hepatitis B.","volume":"23","author":"Kato","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R63-3-20241201","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/jvi.68.4.2671-2676.1994","article-title":"Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen.","volume":"68","author":"Yamamoto","year":"1994","journal-title":"J Virol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22881","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200905001-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:10:58Z","timestamp":1733040658000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200905001-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":61,"journal-issue":{"issue":"Suppl. 5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22881","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}